GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (WBO:BMYS) » Definitions » 3-Year FCF Growth Rate

Bristol-Myers Squibb Co (WBO:BMYS) 3-Year FCF Growth Rate : 1.10% (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Bristol-Myers Squibb Co 3-Year FCF Growth Rate?

Bristol-Myers Squibb Co's Free Cash Flow per Share for the three months ended in Mar. 2024 was €1.16.

During the past 12 months, Bristol-Myers Squibb Co's average Free Cash Flow per Share Growth Rate was 17.40% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 1.10% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 10.10% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 21.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Bristol-Myers Squibb Co was 69.60% per year. The lowest was -41.30% per year. And the median was 14.75% per year.


Competitive Comparison of Bristol-Myers Squibb Co's 3-Year FCF Growth Rate

For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bristol-Myers Squibb Co's 3-Year FCF Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Bristol-Myers Squibb Co's 3-Year FCF Growth Rate falls into.



Bristol-Myers Squibb Co 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Bristol-Myers Squibb Co  (WBO:BMYS) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Bristol-Myers Squibb Co 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Bristol-Myers Squibb Co (WBO:BMYS) Business Description

Address
430 East 29th Street, 14th Floor, New York, NY, USA, 10016
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.

Bristol-Myers Squibb Co (WBO:BMYS) Headlines

No Headlines